Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Circular RNAs as a novel player in synaptic transmission and neuropsychiatric disorders
    Published on 2025-05-06
    1 year ago
  • Sequential decreases in basolateral amygdala response to threat predict failure to recover from PTSD
    Published on 2025-05-03
    1 year ago
  • A Drd1-cre mouse line with nucleus accumbens gene dysregulation exhibits blunted fentanyl seeking
    Published on 2025-05-02
    1 year ago
  • Development of the McLean Hospital MENTOR Program to enhance mental health career pathways
    Published on 2025-04-30
    1 year ago
  • Changes in nucleus accumbens core translatome accompanying incubation of cocaine craving
    Published on 2025-04-29
    1 year ago
  • A rat model of volitional mutual social interactions
    Published on 2025-04-25
    1 year ago
  • Comparing neuromodulation targets to reduce cigarette craving and withdrawal: a randomized clinical trial
    Published on 2025-04-25
    1 year ago
« Previous 1 … 46 47 48 49 50 … 143 Next »
Journal of Psychopharmacology
  • Effects of erythropoietin on cognitive impairment and prefrontal cortex activity across affective disorders: A randomized, double-blinded, placebo-controlled trial
    Published on 2024-03-23
    2 years ago
  • Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part I
    Published on 2024-03-18
    2 years ago
  • Common pitfalls, and how to avoid them, in child and adolescent psychopharmacology: Part II
    Published on 2024-03-18
    2 years ago
  • A proposal for reducing maximum target doses of drugs for psychosis: Reviewing dose–response literature
    Published on 2024-03-18
    2 years ago
  • Proportion of Antipsychotics with CYP2D6 Pharmacogenetic (PGx) Associations Prescribed in an Early Intervention in Psychosis (EIP) Cohort: A Cross-Sectional Study
    Published on 2024-03-18
    2 years ago
  • Specific adverse outcomes associated with selective serotonin reuptake inhibitors use in COVID-19 patients might be potentiated by remdesivir use
    Published on 2024-03-14
    2 years ago
  • Brain-derived neurotrophic factor Val66Met and CYP2B6 polymorphisms as predictors for ketamine effectiveness in patients with treatment-resistant depression
    Published on 2024-03-13
    2 years ago
« Previous 1 … 46 47 48 49 50 … 145 Next »
European Neuropsychopharmacology
  • Chemical cousins with contrasting behavioural profiles: MDMA users and methamphetamine users differ in social-cognitive functions and aggression
    Published on 2024-04-20
    2 years ago
  • Antidepressants compared to placebo for people with binge eating disorder: A systematic review and meta-analysis
    Published on 2024-04-20
    2 years ago
  • Prescribing therapeutic apps within National Health Services: The critical role of evaluation and monitoring
    Published on 2024-04-20
    2 years ago
  • Antidepressant use in bipolar disorder: Shifting focus from ‘Whether’ to ‘Whom’
    Published on 2024-04-19
    2 years ago
  • Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials
    Published on 2024-04-04
    2 years ago
  • Eli Robins: The grandfather of DSM-III
    Published on 2024-03-27
    2 years ago
  • How do lipids fit into the picture of severe mental health disorders? A missing pathophysiologic link or just a consequence of behavior and treatment
    Published on 2024-03-22
    2 years ago
« Previous 1 … 46 47 48 49 50 … 166 Next »

   Pharma Pub